A Chinese pharmaceutical company has injected hundreds of thousands of people with experimental Covid-19 vaccines, as its Western counterparts warn against administering mass vaccinations before rigorous scientific studies are complete. China National Biotec Group Co., a subsidiary of state-owned Sinopharm, has given two experimental vaccine candidates to hundreds of thousands of people under an emergency-use … Read more
A Chinese pharmaceutical maker is in talks with several countries to get emergency approval to use an experimental Covid-19 vaccine, developed with the Chinese military, before the completion of large-scale safety and effectiveness trials, according to a senior executive at the company. Early distribution by CanSino Biologics Inc. would give the company a head start … Read more
SUZHOU/BEIJING: Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental COVID-19 vaccine, its co-founder said on Saturday. China‘s success in driving down COVID-19 infections has made it harder to conduct large-scale vaccine trials, and so far only a few countries … Read more